Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...

Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...

最常用的mpox疫苗提供对该疾病的部分免疫，但并不总是能够预防严重症状或疾病传播。与目前许可的改良安卡拉牛痘 (MVA)疫苗相比，Moderna公司的一种新的mRNA候选疫苗mRNA-1769更有效地限制了感染m痘病毒致死株的灵长类动物的症状和疾病持续时间。

M痘的爆发，不只让社会重新检视自身的防疫和保健意识，也让大众注意到社会上鲜为人知的暗角，躲藏着一些大多数人平时不愿意讨论和面对的歧视、厌恶和不平等。今年8月中，世界卫生组织（WHO）宣布由非洲地区（包括刚果、中非和西非等区域）开始爆发的M痘疫情，为“ ...

As of now, when it comes to protection against prevalent diseases, Dr Gagandeep Kang, a renowned virologist, points that our ...

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

China aprobó el lunes ensayos clínicos para su primera vacuna contra el mpox. La dosis, desarrollada por el Instituto de ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox ...